CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains
- PMID: 29158404
- PMCID: PMC5754766
- DOI: 10.1073/pnas.1708252114
CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains
Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major human pandemic. Germline-encoded mycolyl lipid-reactive (GEM) T cells are donor-unrestricted and recognize CD1b-presented mycobacterial mycolates. However, the molecular requirements governing mycolate antigenicity for the GEM T cell receptor (TCR) remain poorly understood. Here, we demonstrate CD1b expression in TB granulomas and reveal a central role for meromycolate chains in influencing GEM-TCR activity. Meromycolate fine structure influences T cell responses in TB-exposed individuals, and meromycolate alterations modulate functional responses by GEM-TCRs. Computational simulations suggest that meromycolate chain dynamics regulate mycolate head group movement, thereby modulating GEM-TCR activity. Our findings have significant implications for the design of future vaccines that target GEM T cells.
Keywords: CD1b; GEM T cells; Mycobacterium tuberculosis; molecular dynamics; mycolate lipids.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
How T cells grasp mycobacterial lipid antigens.Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13312-13314. doi: 10.1073/pnas.1719260115. Epub 2017 Dec 7. Proc Natl Acad Sci U S A. 2017. PMID: 29217637 Free PMC article. No abstract available.
References
-
- Wallis RS, et al. Tuberculosis–Advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect Dis. 2016;16:e34–e46. - PubMed
-
- Nguipdop-Djomo P, Heldal E, Rodrigues LC, Abubakar I, Mangtani P. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: A retrospective population-based cohort study. Lancet Infect Dis. 2016;16:219–226. - PubMed
-
- O’Garra A, et al. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527. - PubMed
-
- Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015;264:74–87. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
